Cargando…
Targeting Gastric Cancer Stem Cells to Enhance Treatment Response
Gastric cancer (GC) was the fourth deadliest cancer in the world in 2020, and about 770,000 people died from GC that year. The death of patients with GC is mainly caused by the metastasis, recurrence, and chemotherapy resistance of GC cells. The cancer stem cell theory defines cancer stem cells (CSC...
Autores principales: | Rao, Xionghui, Zhang, Chaojun, Luo, Huixing, Zhang, Jianbao, Zhuang, Zhehong, Liang, Zhihao, Wu, Xiaobin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496718/ https://www.ncbi.nlm.nih.gov/pubmed/36139403 http://dx.doi.org/10.3390/cells11182828 |
Ejemplares similares
-
Down-Regulated CLDN10 Predicts Favorable Prognosis and Correlates With Immune Infiltration in Gastric Cancer
por: Rao, XiongHui, et al.
Publicado: (2021) -
Contrast‐enhanced CT‐based radiomic analysis for determining the response to anti‐programmed death‐1 therapy in esophageal squamous cell carcinoma patients: A pilot study
por: Yang, Qinzhu, et al.
Publicado: (2023) -
MicroRNA-181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A
por: Yu, Junhui, et al.
Publicado: (2018) -
Identifying and targeting cancer stem cells in the treatment of gastric cancer
por: Bekaii‐Saab, Tanios, et al.
Publicado: (2017) -
GASC1 promotes glioma progression by enhancing NOTCH1 signaling
por: Xiao, Zhengzheng, et al.
Publicado: (2021)